Changes in progenitor cell population in breast may be overlooked factor in breast cancer

December 17, 2012

The DNA mutations that accumulate over time as women age are not the sole contributor to the higher frequency of breast cancer in women over 50, Mark LaBarge, PhD, a researcher at Lawrence Berkeley National Laboratory (LBNL) reported on Dec. 17 in a presentation at the American Society for Cell Biology Annual Meeting in San Francisco.

Changes in the populations of progenitor cells in breast tissue may be a powerful and until now overlooked factor in breast cancer and aging, he said.

According to U.S. breast cancer statistics, over 75 percent of the 200,000 women diagnosed each year are 50 years of age and older.

The popular hypothesis that accumulating gene mutations drive the connection between aging and cancer breaks down on closer study, according to Dr. LaBarge, because the same sets of mutations commonly detected in cancers in older women are often found in cancers in younger women.

By analyzing a wide sample of normal epithelial breast cells taken during noncancer surgeries of women ages 16 to 91 years old, the LaBarge lab discovered that the aging process results in decreased proportions of myoepithelial cells, which are thought to suppress malignant growth, and a simultaneous increase in multipotent progenitors including faulty luminals and few myoeps. These are thought to be the etiological roots of some breast cancers.

The mammary gland is a network of ducts composed of two layers of epithelial cells ⎯ the inner milk-producing luminal cells and the outer luminal-supporting myoepithelial (or "myoep") cells. Both types develop from progenitor cells -- a small fraction of the cells in the gland that retain the ability to divide.

Progenitor cells are thought to be much more likely to be transformed into tumor cells.

Dr. LaBarge believes that in older women the progenitor cells that normally maintain both types of cells in mammary glands are unable to keep the balance between the lineages. Progenitor cells in older women are less responsive to cues in the breast microenvironment that would promote differentiation into myoepithelial cells in younger women.

The breast microenvironment is a powerful shaper of cell fate, and changes brought on by aging alone, such as altered endocrine profiles, do play a part. But the implication in this new study, said Dr. LaBarge, is that aging leaves women more susceptible to malignant transformation by increasing the potential pool of target cells and decreasing the ability to contain malignancies.
-end-
Funding from National Institute on Aging (R00AG033176 and R01AG040081), US Department of Energy, Low Dose Radiation Research Program (DE-AC02-05CH11231), and US Department of Defense, Breast Cancer Research Program (BC060444).

CONTACTS:

Mark A. LaBarge, PhD
Life Sciences Division
Lawrence Berkeley National Laboratory
malabarge@lbl.gov
510-486-4544

Press contact at LBNL:

Lynn Yarris
lcyarris@lbl.gov

ASCB press contacts:

John Fleischman
jfleischman@ascb.org
513-706-0212

Cathy Yarbrough
Cyarbrough@ascb.org
858-243-1814

AUTHOR PRESENTS:

"Aging-related changes make mammary epithelia more vulnerable to cancer: A story of altered stem cells," Monday, Dec. 17, 2012, 12:30𔃀 pm, Session: Tumor Microenvironment, presentation: 1674, poster: B1445, Exhibit Halls A-C.

American Society for Cell Biology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.